Paul Graham, CEO of Janus Henderson alternatives subsidiary AlphaGen Capital, has left after seven years with the firm.
Janus Henderson said the move follows a review of its alternatives business. The AlphaGen distribution team will move back under Janus Henderson but there will be no changes to the funds, which continue to be managed by Janus Henderson investment teams. Graham was responsible for the group's alternatives strategies, which represent around $17bn, and was also an investment committee member on the multi-manager alternative products. He joined Henderson in April 2011 with the acquisition of alternative investments specialist AlphaGen as part of the Gartmore deal. Graham moved to Al...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
